TITLE:
New directions in cardiac stem cell therapy: An update for clinicians
AUTHORS:
Sarabjeet Singh, Mohammad Kashif, Neil Bhambi, Rajendra R. Makkar, James S. Forrester
KEYWORDS:
Cardiac Stem Cells; Myocardial Regeneration; Therapy
JOURNAL NAME:
World Journal of Cardiovascular Diseases,
Vol.2 No.3,
July
23,
2012
ABSTRACT: The emergence of cardiac stem cell therapy can be traced to late 2001, when studies in small animal models of myocardial infarction suggested that stem cells could engraft, proliferate, and regenerate myo-cardium. Subsequent animal laboratory studies showed improved cardiac function, perfusion and survival compared to controls (Figure 1). Within two years, the first clinical trials of stem cell therapy began to appear, and we now have several trials of intracoronary infusion of bone marrow cells with more than one year follow-up. Although this clinical therapy has proven to be safe, the magnitude of improvement in objective measures like ejection fraction has been modest, and the therapy has not entered clinical practice. In the absence of a large prospective randomized trial, the field has moved back to the laboratory. This manuscript aims to provide clinicians with a broad overview of this complex field by briefly reviewing the existing status of clinical myocardial regeneration therapy, then describing selected examples from the laboratory research approaches that may provide a platform for new and potentially increasingly effective clinical strategies.